Akers Biosciences, Inc. Disclosure


Akers Biosciences, Inc. (NASDAQ: AKER) is a client of PCG Advisory, Inc. AKER has an agreement in place to pay PCG a monthly cash fee of $8,000, for three months (April 2020 – June 2020), for PCG investor awareness and investor relations advisory services.

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. PCG investor awareness and advisory services include multimedia marketing and other awareness services.